Rebalix
Logo XtrackersXtrackers · sheet of 10 September 2026
ETF sheet · official issuer and register data

Xtrackers Msci Usa Swap Ii UCITS ETF 1d

IE000FW16TX1 · IE000FW16TX1 · USD · domicile Ireland
Equity · United StatesSFDR art. 6 (inferred)
Index tracked: MSCI Total Return Net USA Index (USD)
TER
0.04%+ trans. 0.00%
Fund size
260 m EUR
Tracking difference
not computable
🇮🇹 tax rate
white list not published
Replication
Synthetic (swap)
Income
Distributing
Launch 18 Mar 2026 · costs from the KID as of 2 Sept 2026 · 52 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The fund is passively managed. INVESTMENT OBJECTIVE: The aim is for your investment to track the performance, before fees and expenses, of the MSCI USA Index (index) which is designed to reflect the performance of shares of certain large and medium capitalisation companies in the USA. DESCRIPTION OF INDEX: The companies making up the index are large and medium sized companies based on the combined value of a company’s readily available shares as compared to other companies. A company’s weighting in the index depends on its relative size. INDEX…

Performance since series start (in euro) — base 100

18 Mar 20268 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
11896115
High 118 (13 Aug 2026) · low 96 (30 Mar 2026) · last 115. Past performance is not indicative of future results.

Returns in euro

1 yearseries too young
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start+15.4%

Risk · 1 / 3 / 5 years

Volatility (ann.)
Max drawdown
Sharpe
Sortino
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IE000FW16TX1 · IE000FW16TX11
RebalixIE000FW16TX1 · IE000FW16TX1 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years
Not honestly computable: index series not published by the issuer

Distributions · per share, in USD

last 12 months: 0.0378 USD (0.12% of NAV) · 1 months of history: not a full year · last ex-date 19 Aug 2026
YearPaymentsTotal (USD)
202610.0378

Holdings

Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 2 Sept 2026 · 52 securities · top-10 weight = 52.9%
Top holdingsWeight
NASDAQ INC9.9%
FRANKLIN TEMPLETON7.9%
NETFLIX6.5%
HAMILTON LANE CLASS A4.6%
ATI4.6%
JAZZ PHARMACEUTICALS PLC4.3%
TERAWULF4.1%
PLANET LABS CLASS A4.0%
WALMART INC3.6%
BROADCOM INC3.4%

Listing venues

ESMA register (FIRDS) and official exchange lists
USOA · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 5 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · etf.dws.com/download/asset/a7721b0f-fd28-4599-b891-762bb39f670b
Factsheet · etf.dws.com/download/asset/f44b94e3-bcc3-423d-b003-925ea158d2ef
Prospectus · etf.dws.com/download/asset/25f159fa-a123-4a77-9751-682976c15095
The live sheet, always up to date
rebalix.com/en/etf/IE000FW16TX1
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · IE000FW16TX1 · IE000FW16TX12